The Institute for OneWorld Health Receives BMGF Grant to Combat Diarrheal Disease
Silencing a Global Health Challenge that Kills Two Million Children a Year.
1 November 2006-The Institute for OneWorld Health (San Francisco, CA) will receive a $46.07 million grant from the Bill and Melinda Gates Foundation (BMGF) to explore alternative cures for diarrheal disease. This is the largest grant the BMGF has ever awarded to an organization to address diarrheal disease, the overlooked global health challenge that kills more than two million children annually.
The grant is focused on identifying and developing new approaches to curing diarrheal disease, a chronic and pervasive killer whose bacterial sources are varied, but widespread in the developing world.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
